aTyr Pharma Lands $75,600,000 New Funding

  • Feed Type
  • Date
    5/6/2015
  • Company Name
    aTyr Pharma
  • Mailing Address
    3565 General Atomics Court San Diego, CA 92121 USA
  • Company Description
    aTyr Pharma (NASDAQ: LIFE) has developed proprietary methods for discovering Physiocrines, extracellular proteins that are derived from the tRNA synthetase family of enzymes, and which were predominantly overlooked by other genomic and secretome discovery efforts.
  • Website
    http://www.atyrpharma.com
  • Transaction Type
    IPO
  • Transaction Amount
    $75,600,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy